KMT2A and acute myeloid leukemia: VDR is overexpressed in AML subtypes and predicts poor prognosis: Patients with AML inv(16)/t(16;16), complex AML, or t(11q23)/MLL exhibited significantly elevated VDR mRNA expression than hematopoietic stem cells (HSC) controls (Figure 1A).